Literature DB >> 15046230

Anorectal dysfunction increases with time following radiation therapy for carcinoma of the prostate.

Eric E K Yeoh1, Richard H Holloway, Robert J Fraser, Rochelle J Botten, Addolorata C Di Matteo, James W E Moore, Mark N Schoeman, F Dylan L Bartholomeusz.   

Abstract

OBJECTIVES: To characterize the prevalence and pathophysiology of anorectal dysfunction up to 2 yr following radiation therapy (RT) for localized carcinoma of the prostate.
METHODS: Thirty-eight patients, median age 68 (range 60-82) yr with localized prostate carcinoma randomly assigned to one of two radiation dose schedules, underwent evaluation of the following variables of anorectal function before RT, as well as 4-6 wk and 1 and 2 yr after its completion: (1) symptoms, (2) anorectal motility, (3) anorectal sensory function, and (4) anal sphincteric morphology.
RESULTS: There was a persistent increase in anorectal symptoms after RT. At 2 yr, bowel frequency, urgency, and fecal incontinence were increased in 50%, 47%, and 26% of patients, respectively. After RT, there were progressive reductions of (1) basal anal pressures, (2) anal pressures in response to squeeze and increased intra-abdominal pressure, (3) rectal compliance, and (4) rectal volumes associated with sensory perception and the desire to defecate. The thickness of the external anal sphincter increased with time after RT. No difference was observed between the patients in the two radiation dose schedules.
CONCLUSIONS: Anorectal dysfunction following RT for prostate carcinoma is an underestimated cause of morbidity, which progresses with time. The prevalence and pathophysiology of anorectal dysfunction is similar after treatment with two commonly used radiation dose schedules.

Entities:  

Mesh:

Year:  2004        PMID: 15046230     DOI: 10.1111/j.1572-0241.2004.04037.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  11 in total

1.  Effectiveness of sacral nerve stimulation in fecal incontinence after multimodal oncologic treatment for pelvic malignancies: a multicenter study with 2-year follow-up.

Authors:  M Schiano di Visconte; G A Santoro; N Cracco; G Sarzo; G Bellio; M Brunner; Z Cui; K E Matzel
Journal:  Tech Coloproctol       Date:  2018-01-08       Impact factor: 3.781

Review 2.  Effects of radiation upon gastrointestinal motility.

Authors:  Mary F Otterson
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

Review 3.  Neurophysiological testing in anorectal disorders.

Authors:  Jose M Remes-Troche; Satish S C Rao
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2008-06       Impact factor: 3.869

Review 4.  Systematic review of hyperbaric oxygen therapy for the treatment of non-neurological soft tissue radiation-related injuries.

Authors:  Benjamin L Hoggan; Alun L Cameron
Journal:  Support Care Cancer       Date:  2014-03-29       Impact factor: 3.603

Review 5.  Systematic review: anal and rectal changes after radiotherapy for prostate cancer.

Authors:  Robin Krol; Robert Jan Smeenk; Emile N J T van Lin; Eric E K Yeoh; Wim P M Hopman
Journal:  Int J Colorectal Dis       Date:  2013-10-23       Impact factor: 2.571

6.  Assessment of acute bowel function after radiotherapy for prostate cancer: Is it accurate enough?

Authors:  M Bonet; L Cayetano; M Núñez; E Jovell-Fernández; A Aguilar; Y Ribas
Journal:  Clin Transl Oncol       Date:  2017-09-12       Impact factor: 3.405

7.  Effect of neoadjuvant chemoradiation on postoperative fecal continence and anal sphincter function in rectal cancer patients.

Authors:  Alexander P Pietsch; Rainer Fietkau; Günther Klautke; Thomas Foitzik; Ernst Klar
Journal:  Int J Colorectal Dis       Date:  2007-05-12       Impact factor: 2.571

8.  Impact of late anorectal dysfunction on quality of life after pelvic radiotherapy.

Authors:  Robin Krol; Robert Jan Smeenk; Emile N J T van Lin; Wim P M Hopman
Journal:  Int J Colorectal Dis       Date:  2012-10-19       Impact factor: 2.571

9.  Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose.

Authors:  Yoo-Kang Kwak; Sea-Won Lee; Chul Seung Kay; Hee Hyun Park
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

10.  Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical Review.

Authors:  Paul Sargos; Mame Daro Faye; Manon Bacci; Stéphane Supiot; Igor Latorzeff; David Azria; Tamim M Niazi; Te Vuong; Véronique Vendrely; Renaud de Crevoisier
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.